Skip to content

AARD AARD Other Income (Expense)

Other Income (Expense) at other companies

Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$409.8K-37.8%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
-$2.73M-13.2%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$5.8M-41.1%
Arvinas logo
ArvinasARVN
$6.3M-46.2%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$53K-35.4%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$6M-40.0%

Other financials

Income statement

See full
Revenue-
Operating income-$22.5M-115%
Net income-$21.6M-132%
EPS (diluted)-$0.99-39.4%

Balance sheet

See full
Cash & equivalents$62.4M+136%
Total debt$336.0K-53.7%
Total equity$87.0M-42.3%
Total assets$98.6M-37.2%

Cash flow

See full
Operating cash flow-$18.9M-65.7%
CapEx--100%
Free cash flow-$16.8M-117%

Valuation

See full
Market cap$124.35M-58.6%
Enterprise value$62.25M-77.4%

Returns & leverage

See full
Return on equity-58.8%
Debt / equity0.0×
Current ratio8.1×-17.8×

Where this comes from

Reported directly by AARD in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The official record: AARD’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about AARD's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AARD's other income (expense)?
AARD (AARD) reported other income (expense) of $876K in Q1 2026.
How has AARD's other income (expense) changed year-over-year?
AARD's other income (expense) decreased by 24.5% year-over-year, from $1.16M to $876K.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.